Taurine directly binds to oligomeric amyloid-β and recovers cognitive deficits in Alzheimer model mice

Advances in Experimental Medicine and Biology

Volumn 975, Issue , 2017, Pages 233-241

  Jang, HoChung ^a,b,c   Lee, Sejin ^a,b,c   Choi, Sujin Lea ^a   Kim, Hye Yun ^c   Baek, Seungyeop ^a,c   Kim, YoungSoo ^c  

^a Korea Institute of Science and Technology   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Alzheimer s disease; Amyloid ; Dementia; Taurine

Indexed keywords

AMYLOID BETA PROTEIN; TAURINE;

ADULT; ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; MALE; MAZE TEST; MOUSE; NONHUMAN; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; ANIMAL; C57BL MOUSE; COGNITION; DISEASE MODEL; DRUG EFFECT; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION; DISEASE MODELS, ANIMAL; MAZE LEARNING; MICE; MICE, INBRED C57BL; TAURINE;

EID: 85029325366     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-94-024-1079-2_21     Document Type: Article

References (16)

1. Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H, Takihara K, Hasegawa H, Yamagami T, Ishiyama T et al (1985) Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 8(5):276–282
2. Choi JW, Kim HY, Jeon M, Kim DJ, Kim Y (2012) Efficient access to highly pure beta-amyloid peptide by optimized solid-phase synthesis. Amyloid 19(3):133–137. doi:10.3109/13506129.2 012.700287
3. Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG (2015) Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease. Front Cell Neurosci 9:191. doi:10.3389/fncel.2015.00191
4. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148(6):1204– 1222. doi:10.1016/j.cell.2012.02.040
5. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72(1):101–163
6. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17(6):157–165
7. Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AH, Verveer M, de Groot LR, Smith VD, Rangarajan S, Rodriguez JJ, Orre M, Hol EM (2012) GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One 7(8):e42823. doi:10.1371/journal.pone.0042823
8. Kim HY, Kim HV, Yoon JH, Kang BR, Cho SM, Lee S, Kim JY, Kim JW, Cho Y, Woo J, Kim Y (2014) Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer’s disease. Sci Rep 4:7467. doi:10.1038/srep07467
9. Kim HY, Lee DK, Chung BR, Kim HV, Kim Y (2016) Intracerebroventricular injection of amyloid-beta peptides in normal mice to acutely induce Alzheimer-like cognitive deficits. J Vis Exp 109. doi:10.3791/53308
10. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer’s-related amyloid beta oligomers. J Neurosci 24(45):10191–10200. doi:10.1523/JNEUROSCI.3432-04.2004
11. Matsuyama Y, Morita T, Higuchi M, Tsujii T (1983) The effect of taurine administration on patients with acute hepatitis. Prog Clin Biol Res 125:461–468
12. Miao J, Zhang J, Zheng L, Yu X, Zhu W, Zou S (2012) Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells. Amino Acids 42(6):2417–2428. doi:10.1007/s00726-011-1047-3
13. Richter L, Munter LM, Ness J, Hildebrand PW, Dasari M, Unterreitmeier S, Bulic B, Beyermann M, Gust R, Reif B, Weggen S, Langosch D, Multhaup G (2010) Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization. Proc Natl Acad Sci U S A 107(33):14597–14602. doi:10.1073/pnas.1003026107
14. Schaffer SW, Azuma J, Madura JD (1995) Mechanisms underlying taurine-mediated alterations in membrane function. Amino Acids 8(3):231–246. doi:10.1007/BF00806821
15. Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298(5594):789–791. doi:10.1126/science.1074069
16. Sheng M, Sabatini BL, Sudhof TC (2012) Synapses and Alzheimer’s disease. Cold Spring Harb Perspect Biol 4(5). doi:10.1101/cshperspect.a005777